S&P 500   3,894.16 (-0.20%)
DOW   31,526.77 (-0.03%)
QQQ   322.67 (-0.28%)
AAPL   126.85 (-0.74%)
MSFT   235.40 (-0.65%)
FB   265.53 (+0.23%)
GOOGL   2,070.23 (+0.03%)
TSLA   709.91 (-1.19%)
AMZN   3,147.00 (+0.03%)
NVDA   549.82 (-0.70%)
BABA   240.05 (-0.68%)
CGC   35.08 (+1.01%)
GE   13.04 (-0.53%)
MU   94.28 (-0.51%)
NIO   45.94 (-7.68%)
AMD   86.06 (-0.38%)
T   28.29 (+0.71%)
F   11.99 (+0.08%)
ACB   11.48 (+3.99%)
DIS   197.65 (+1.37%)
BA   223.07 (-0.59%)
NFLX   550.62 (+0.00%)
BAC   35.83 (+0.11%)
S&P 500   3,894.16 (-0.20%)
DOW   31,526.77 (-0.03%)
QQQ   322.67 (-0.28%)
AAPL   126.85 (-0.74%)
MSFT   235.40 (-0.65%)
FB   265.53 (+0.23%)
GOOGL   2,070.23 (+0.03%)
TSLA   709.91 (-1.19%)
AMZN   3,147.00 (+0.03%)
NVDA   549.82 (-0.70%)
BABA   240.05 (-0.68%)
CGC   35.08 (+1.01%)
GE   13.04 (-0.53%)
MU   94.28 (-0.51%)
NIO   45.94 (-7.68%)
AMD   86.06 (-0.38%)
T   28.29 (+0.71%)
F   11.99 (+0.08%)
ACB   11.48 (+3.99%)
DIS   197.65 (+1.37%)
BA   223.07 (-0.59%)
NFLX   550.62 (+0.00%)
BAC   35.83 (+0.11%)
S&P 500   3,894.16 (-0.20%)
DOW   31,526.77 (-0.03%)
QQQ   322.67 (-0.28%)
AAPL   126.85 (-0.74%)
MSFT   235.40 (-0.65%)
FB   265.53 (+0.23%)
GOOGL   2,070.23 (+0.03%)
TSLA   709.91 (-1.19%)
AMZN   3,147.00 (+0.03%)
NVDA   549.82 (-0.70%)
BABA   240.05 (-0.68%)
CGC   35.08 (+1.01%)
GE   13.04 (-0.53%)
MU   94.28 (-0.51%)
NIO   45.94 (-7.68%)
AMD   86.06 (-0.38%)
T   28.29 (+0.71%)
F   11.99 (+0.08%)
ACB   11.48 (+3.99%)
DIS   197.65 (+1.37%)
BA   223.07 (-0.59%)
NFLX   550.62 (+0.00%)
BAC   35.83 (+0.11%)
S&P 500   3,894.16 (-0.20%)
DOW   31,526.77 (-0.03%)
QQQ   322.67 (-0.28%)
AAPL   126.85 (-0.74%)
MSFT   235.40 (-0.65%)
FB   265.53 (+0.23%)
GOOGL   2,070.23 (+0.03%)
TSLA   709.91 (-1.19%)
AMZN   3,147.00 (+0.03%)
NVDA   549.82 (-0.70%)
BABA   240.05 (-0.68%)
CGC   35.08 (+1.01%)
GE   13.04 (-0.53%)
MU   94.28 (-0.51%)
NIO   45.94 (-7.68%)
AMD   86.06 (-0.38%)
T   28.29 (+0.71%)
F   11.99 (+0.08%)
ACB   11.48 (+3.99%)
DIS   197.65 (+1.37%)
BA   223.07 (-0.59%)
NFLX   550.62 (+0.00%)
BAC   35.83 (+0.11%)
Log in
NASDAQ:CHNA

Loncar China BioPharma ETF Stock Forecast, Price & News

$39.26
+1.39 (+3.67 %)
(As of 03/1/2021 12:00 AM ET)
Add
Today's Range
$38.49
Now: $39.27
$39.37
50-Day Range
$33.59
MA: $38.36
$41.19
52-Week Range
$19.00
Now: $39.27
$42.00
Volume4,020 shs
Average Volume7,567 shs
Market Capitalization$15.71 million
P/E RatioN/A
Dividend Yield0.41%
BetaN/A

Basic Details

Issuer Exchange Traded Concepts
Fund NameLoncar China Biopharma ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:CHNA
Inception Date8/14/2018
Fund ManagerDenise M. Krisko, Habib Moudachirou
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkLoncar China BioPharma Index
CategorySector
FocusHealth Care
Development LevelEmerging Markets
RegionAsia-Pacific

Fund Statistics

Assets Under Management$11.75 million
Average Daily Volume$4,075.70
Discount/Premium-0.02%

ETF Expenses

Management Fee0.79%
Other Expenses0.00%
Total Expenses0.79%
Fee Waiver0.00%
Net Expenses0.79%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorExchange Traded Concepts, LLC
CustodianU.S. Bank, N.A.
DistributorQuasar Distributors, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market Maker

Geographic Exposure of CHNA

Currency Exposure of CHNA

Sector Exposure of CHNA

Industry Exposure of CHNA

$39.26
+1.39 (+3.67 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHNA News and Ratings via Email

Sign-up to receive the latest news and ratings for CHNA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Loncar China BioPharma ETF (NASDAQ:CHNA) Frequently Asked Questions

What stocks does MarketBeat like better than Loncar China BioPharma ETF?

Wall Street analysts have given Loncar China BioPharma ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Loncar China BioPharma ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Loncar China BioPharma ETF?

Loncar China BioPharma ETF saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 18,500 shares, an increase of 270.0% from the January 28th total of 5,000 shares. Based on an average trading volume of 5,500 shares, the days-to-cover ratio is currently 3.4 days.
View Loncar China BioPharma ETF's Short Interest
.

How has Loncar China BioPharma ETF's stock been impacted by Coronavirus (COVID-19)?

Loncar China BioPharma ETF's stock was trading at $24.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CHNA shares have increased by 61.5% and is now trading at $39.2650.
View which stocks have been most impacted by COVID-19
.

How often does Loncar China BioPharma ETF pay dividends? What is the dividend yield for Loncar China BioPharma ETF?

Loncar China BioPharma ETF announced an annual dividend on Tuesday, December 29th. Investors of record on Thursday, December 31st will be given a dividend of $0.155 per share on Monday, January 4th. This represents a dividend yield of 0.48%. The ex-dividend date of this dividend is Wednesday, December 30th.
View Loncar China BioPharma ETF's dividend history
.

Is Loncar China BioPharma ETF a good dividend stock?

Loncar China BioPharma ETF pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.41%.
View Loncar China BioPharma ETF's dividend history.

What other stocks do shareholders of Loncar China BioPharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China BioPharma ETF investors own include Baidu (BIDU), salesforce.com (CRM), (CGC), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), (APHA), Advanced Micro Devices (AMD) and Analog Devices (ADI).

What is Loncar China BioPharma ETF's stock symbol?

Loncar China BioPharma ETF trades on the NASDAQ under the ticker symbol "CHNA."

How do I buy shares of Loncar China BioPharma ETF?

Shares of CHNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Loncar China BioPharma ETF's stock price today?

One share of CHNA stock can currently be purchased for approximately $39.27.

How much money does Loncar China BioPharma ETF make?

Loncar China BioPharma ETF has a market capitalization of $15.71 million.


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.